Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2417 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
23 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-02-17 | 2022-03-24 | 155137 |
| TEVA-PRAZOSIN | 5MG | TABLET | Resolved | 2022-02-10 | 2022-03-24 | 154729 |
| TEVA-PRAZOSIN | 2MG | TABLET | Resolved | 2022-01-27 | 2022-03-24 | 153736 |
| TEVA-TOPISONE | 0.05% | OINTMENT | Resolved | 2022-01-20 | 2022-03-24 | 153147 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2022-01-20 | 2022-03-24 | 153141 |
| TEVA-TECNAL C 1/2 | 30MG 330MG 40MG 50MG | CAPSULE | Resolved | 2021-12-17 | 2022-03-24 | 151439 |
| TEVA-ATOMOXETINE | 80MG | CAPSULE | Resolved | 2021-09-23 | 2022-03-24 | 146122 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2021-05-13 | 2022-03-18 | 139309 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2022-01-27 | 2022-03-18 | 153730 |
| TEVA-OXYCODAN | 5MG 325MG | TABLET | Resolved | 2022-03-04 | 2022-03-09 | 156067 |
| TEVA-TEMOZOLOMIDE | 100MG | CAPSULE | Resolved | 2022-03-04 | 2022-03-09 | 156061 |
| TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2022-02-24 | 2022-03-09 | 155554 |
| TEVA-TEMOZOLOMIDE | 140MG | CAPSULE | Resolved | 2022-01-27 | 2022-03-09 | 153706 |
| TEVA-OMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-01-20 | 2022-03-09 | 153177 |
| TEVA-TOPISONE | 0.05% | CREAM | Resolved | 2022-01-20 | 2022-03-09 | 153150 |
| TEVA-TEMOZOLOMIDE | 250MG | CAPSULE | Resolved | 2022-01-20 | 2022-03-09 | 153135 |
| TEVA-BETAHISTINE | 8MG | TABLET | Resolved | 2022-01-07 | 2022-03-09 | 152408 |
| TEVA-CODEINE | 30MG | TABLET | Resolved | 2021-11-04 | 2022-03-09 | 148838 |
| TEVA-ENTACAPONE | 200MG | TABLET | Resolved | 2022-01-20 | 2022-02-25 | 153159 |
| TEVA-LENOLTEC NO. 4 | 60MG 300MG | TABLET | Resolved | 2022-01-27 | 2022-02-25 | 153724 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64606 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64601 |
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64541 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
| ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |